Keyphrases
Randomized Placebo-controlled Trial
100%
Patients with Schizophrenia
100%
Clonidine
100%
Placebo
37%
Sensorimotor Gating
37%
Healthy Controls
25%
PANSS
25%
Sensory Gating
25%
Noradrenergic
25%
Schizophrenic Patients
25%
Randomized Clinical Trial
12%
Placebo-controlled
12%
Treatment Strategy
12%
Effective Treatment
12%
Healthy Individuals
12%
Symptom Severity
12%
Information Processing
12%
Schizophrenia
12%
Placebo Effect
12%
Antipsychotics
12%
Treatment Duration
12%
Safe Treatment
12%
Negative Symptoms
12%
Symptomatology
12%
Group Effect
12%
Low-cost Treatment
12%
Chronic Schizophrenia
12%
Alpha-2 Agonists
12%
INIS
patients
100%
augmentation
100%
control
33%
symptoms
33%
comparative evaluations
33%
levels
11%
reduction
11%
information
11%
sex
11%
cost
11%
brain
11%
clinical trials
11%
processing
11%
Neuroscience
Placebo
100%
Clonidine
100%
Sensory Gating
62%
Information Processing
12%
Agonist
12%
Negative Syndrome
12%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
100%
Clonidine
100%
Randomized Clinical Trial
12%
Negative Syndrome
12%
Symptomatology
12%